GENEVA, Feb. 2 -- SKYMAB BIOTHERAPEUTICS (8 rue de Balzac37000 TOURS) filed a patent application (PCT/EP2025/071359) for "ANTIBODY-DRUG CONJUGATE COMPRISING AN ANTI-PMEL-17 ANTIBODY, AND USES THEREOF" on Jul 24, 2025. With publication no. WO/2026/022310, the details related to the patent application was published on Jan 29, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MERABET, Manel (7 A boulevard de la Petite Rente13011 Marseille)
Abstract: The present invention relates in general to the field of medicine. More particularly, it relates to new antibody-drug conjugates and uses thereof.
...